REPL::Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
Date &Time of Broadcast
07-Jul-2022 19:24:23
Status
Replacement
Announcement Sub Title
Notice of Cessation as Substantial Shareholder - Jaspal Singh Narulla
Announcement Reference
SG220706OTHRU5AA
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Please see attached.
This is to replace the change in interest announcement released by the Company on 6 July 2022 (Announcement Reference No. SG220706OTHRU5AA). There are no other changes to the attachment or contents of the notice of cessation of substantial shareholder interest announcement other than the omission of the Sponsor statement.
This announcement has been prepared by iX Biopharma Ltd. (the Company) and its contents have been reviewed by the Company s Sponsor, UOB Kay Hian Private Limited (the Sponsor), for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited (the SGX-ST) Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr. Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone: (65) 6590 6881.
Additional Details
Person(s) giving notice
Substantial Shareholder(s)/Unitholder(s) (Form 3)
Date of receipt of notice by Listed Issuer
06/07/2022
Attachments
Form 3 Jaspal Final.pdf
if you are unable to view the above file, please click the link below.
_Form 3 Jaspal Final.pdf
Total size =150K
Related Announcements
Related Announcements
06/07/2022 17:22:00